Plain-English translation of NCT07128186 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing a new artificial intelligence screening system designed to catch early memory problems in people with type 2 diabetes. Researchers want to see if this AI tool can accurately identify mild cognitive impairment (subtle memory or thinking changes that don't yet qualify as dementia) before symptoms become serious. You'll be followed for 3 to 5 years and have regular cognitive assessments while researchers study how your blood sugar control affects your memory and thinking abilities.
Many people with type 2 diabetes develop memory and thinking problems, but these changes are often caught too late. This study aims to find a better, earlier way to detect these changes so doctors can intervene sooner and potentially prevent or slow cognitive decline.
You likely qualify if…
You likely don't qualify if…
You will complete cognitive screening tests using an AI-based system at regular study visits over 3 to 5 years. The study will track your blood sugar levels and other diabetes-related measurements alongside your thinking and memory performance. You'll be part of one of two groups—either the normal cognition group or the mild cognitive impairment group—to help researchers understand how the AI tool works and how diabetes affects the brain over time.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China